Skip to main content
. 2018 Nov 5;11(1):13–25. doi: 10.1080/19420862.2018.1532766

Table 5.

Brief details of binding titrations contributing to the study.

Lab Code Assay Platform Assay description Readout Specific for infliximab
1 FRET Europium labelled infliximab and Cy5 labelled TNF form fluorescent complex which is competitively inhibited by unlabelled infliximab Resonance energy transfer Yes
2 SPR Infliximab titrated onto chip coated with anti-Fc and fixed concentration of TNF passed over Response units at binding saturation N/A
8, 18 ELISA Plates coated with TNF, infliximab captured and detected with anti-Kappa chain-HRP and TMB substrate. Absorbance 450nm No
22, 24, 27 ELISA Plates coated with anti-TNF, TNF captured, infliximab captured by bound TNF and detected by anti-infliximab-HRP and TMB substrate Absorbance 450nm Yes
23 ELISA Plates coated with TNF, infliximab captured and detected with anti-IgG -HRP and TMB substrate Absorbance 450nm No